Wuxi AppTec: Net profit increased by 102.6% to 19.15 billion yuan by 2025, continuing to focus on and strengthen the CRDMO business model

LightningPacketLoss · 2026-03-23T13:28:36+00:00

Wuxi AppTec released its 2025 annual report, with operating revenue reaching 45.46 billion yuan, a year-over-year increase of 15.8%; net profit attributable to the parent company was 19.15 billion yuan, a growth of 102.6%. The company focused on enhancing profitability through its CRDMO business and implemented share buyback and dividend distribution plans to reward shareholders, resulting in a significant improvement in overall operational efficiency.

LightningPacketLoss

2026-03-23 13:28:36

Abstract generation in progress

Recently, WuXi AppTec announced its 2025 annual report, stating that the company’s operating revenue was 45.46 billion yuan, an increase of 15.8% year-over-year; net profit attributable to shareholders was 19.15 billion yuan, up 102.6%; non-recurring net profit attributable to shareholders was 13.24 billion yuan, up 32.6%; net operating cash flow was 17.203 billion yuan, a 38.7% increase; and EPS (fully diluted) was 6.4183 yuan.

In its 2025 annual report, the company mentioned that the main changes in its business operations are reflected in the continuous strengthening and optimization of the CRDMO business model. During the reporting period, the company focused on and enhanced this business model, improving overall profitability, which contributed to revenue growth. At the same time, driven by growth in late-stage clinical and commercial projects, production efficiency significantly increased.

Additionally, during the reporting period, the company implemented several share repurchase and dividend plans to reward shareholders. The report shows that the company repurchased shares through centralized bidding and canceled them, demonstrating its commitment to shareholder value. Overall, the company has shown a positive attitude toward improving operational efficiency and shareholder returns.

(WuXi AppTec Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.